CopyFind
I Cefod 100mg Dry Syrup
Ліки 📍 IN

I Cefod 100mg Dry Syrup

115,00 ₹

Аналоги I Cefod 100mg Dry Syrup

Знайдіть доступніші аналоги та дженерики для I Cefod 100mg Dry Syrup.

Інгредієнти

Активний інгредієнт: cefpodoxime proxetil


Опис товару

About I Cefod

I Cefod is a medication containing the active ingredient Cefpodoxime Proxetil, classified as Antibiotic. Cefpodoxime is an oral, third-generation cephalosporin antibiotic available in various generic preparations. It is active against both Gram-positive and Gram-negative organisms with notable exceptions including Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis.

Key Benefits & Uses

  • Used for: INDICATIONS AND USAGE Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains.
  • Used for: Recommended dosages, durations of therapy, and applicable patient populations vary among these infections
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Cefpodoxime Proxetil, the active ingredient in I Cefod, belongs to the Antibiotic class. INDICATIONS AND USAGE Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Recommended dosages, durations of therapy, and applicable patient populations vary among these infections. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking I Cefod. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use I Cefod for extended periods without medical advice.

Знайти в аптеках

Порівняйте місцеві ціни та відстань для I Cefod 100mg Dry Syrup.

Оцінки відвідувачів

Допоможіть іншим — оцініть корисність цієї сторінки.

Оцінок ще немає — будьте першим.